Ramón Guàrdia

Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy

Marta Pratcorona, Salut Brunet, Josep Nomdedéu et al. · Blood · 2013 · 282 citations

Medicine, Hematology, Oncology +12

Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial

Josep‐María Ribera, Albert Oriol, Mireia Morgades et al. · Journal of Clinical Oncology · 2014 · 253 citations · Full text

Medicine, Hematology, Oncology +17

Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia

Mariano Monzó, Salut Brunet, Álvaro Urbano-Ispizúa et al. · Blood · 2006 · 70 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study

Javier de la Rubia, Federico Moscardó, María Gómez et al. · Transfusion and Apheresis Science · 2010 · 59 citations

Medicine, Hematology, Immunology +9

Predictive factors for poor peripheral blood stem cell mobilization and peak CD34+cell count to guide pre-emptive or immediate rescue mobilization.

Juan‐Manuel Sancho, Mireia Morgades, Joan-Ramon Grífols et al. · Cytotherapy · 2012 · 55 citations

Medicine, Hematology, Cell Therapy +15